Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
Limited information is currently available on XL092 (May, 2019).
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|XL092||XL-092|XL 092||MET Inhibitor 51 VEGFR Inhibitor (Pan) 32||XL092 is a receptor tyrosine kinase inhibitor that targets MET and other kinases and also prevents angiogenesis through inhibition of VEGF receptor subtypes (NCI Drug Dictionary).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|
|NCT03845166||Phase I||XL092||A Study of XL092 in Subjects With Solid Tumors||Recruiting|